Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2022-08-28 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
关于取得2项实用新型专利证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Sichuan Zitonggong Pharmaceutical Co., Ltd. about obtaining two utility model patent certificates. It includes details about the patents, their application and authorization dates, and the impact on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no management or board changes, no voting results, no legal proceedings, no capital changes, and no other financial or governance report content. The document is a regulatory announcement about intellectual property achievements, which does not fit into any specific financial report category. Therefore, it falls under the fallback category of Regulatory Filings (RNS). The document length is short and it is not a report publication announcement or certification. Hence, the best classification is Regulatory Filings (RNS) with high confidence.
2022-08-28 Chinese
关于召开2022年第三次临时股东大会通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2022 third extraordinary general meeting of shareholders (临时股东大会) for the company 四川梓橦宫药业股份有限公司. It details the meeting date, voting methods (including online voting), eligibility, agenda items, registration procedures, and contact information. It does not contain financial statements, audit results, or detailed management discussion. It is not a report itself but an announcement about a shareholders meeting. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2022-08-28 Chinese
关于部分募集资金投资项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sichuan Zitonggong Pharmaceutical Co., Ltd. regarding the delay of certain projects funded by raised capital. It details the use of raised funds, reasons for project delays, and includes opinions from the board, independent directors, supervisory board, and the sponsoring institution. The document references regulatory approvals and compliance with securities regulations. It does not contain financial statements or detailed financial performance data but rather focuses on the status and management of capital raised and its investment projects. The document length is under 5,000 characters and is primarily an announcement about the delay of investment projects funded by raised capital. Therefore, it fits best under Capital/Financing Update (CAP) as it updates on the use and progress of fundraising proceeds and related project delays.
2022-08-28 Chinese
2022年半年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (336 characters) indicating that the company's 2022 half-year report and summary have been disclosed on the official exchange platform. It does not contain the actual financial data or report content but directs investors to where the report can be found. This fits the pattern of a Report Publication Announcement (RPA) rather than the actual Interim/Quarterly Report (IR).
2022-08-28 Chinese
平安证券关于梓橦宫公司部分募集资金投资项目延期事项的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed opinion from a sponsoring securities company regarding the delay in certain fundraising investment projects of a listed company. It references regulatory rules related to fundraising and stock issuance, provides detailed financial figures about the fundraising, project progress, and includes formal opinions from the board, independent directors, and supervisory board. The document is not a full annual or interim report, nor is it an earnings release or a call transcript. It is not a simple announcement but a formal verification and opinion on the delay of fundraising investment projects, which is typical of a Capital/Financing Update. The document length is about 3,000 characters, which is substantive but not a full financial report. It is not a report publication announcement or a regulatory filing fallback. Therefore, the best fitting category is Capital/Financing Update (CAP).
2022-08-28 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is titled '股票解除限售公告' which translates to 'Stock Unlocking Announcement' or 'Announcement of Stock Release from Lock-up'. It details the number of shares being unlocked from restrictions, the shareholders involved, their roles, and the reasons for unlocking. It also includes the updated share capital structure after the unlocking. The document is an official announcement regarding the change in the status of restricted shares becoming tradable. It does not contain financial statements, earnings data, or management discussion. It is not a report but an announcement about share capital changes specifically related to unlocking restricted shares. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is short (1809 characters), consistent with an announcement rather than a full report.
2022-08-21 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.